These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9713875)

  • 21. Calcium citrate: reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation.
    Harvey JA; Zobitz MM; Pak CY
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1223-5. PubMed ID: 4055988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study of inhibitory effect of chondroitin polysulfate on stone formation of calcium oxalate].
    Fujisawa M; Arima S; Yachiku S
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1647-54. PubMed ID: 1434267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal inhibition: the effects of polyanions on calcium oxalate crystal growth.
    Fellström B; Danielson BG; Ljunghall S; Wikström B
    Clin Chim Acta; 1986 Aug; 158(3):229-35. PubMed ID: 2429785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Control of urinary risk factors of stones by betulin and lupeol in experimental hyperoxaluria.
    Vidya L; Varalakshmi P
    Fitoterapia; 2000 Sep; 71(5):535-43. PubMed ID: 11449502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
    Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization.
    Laube N; Zimmermann DJ
    Clin Chem Lab Med; 2004; 42(6):665-9. PubMed ID: 15259384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on calcium oxalate monohydrate crystallization: influence of inhibitors.
    Grases F; Kroupa M; Costa-Bauzá A
    Urol Res; 1994; 22(1):39-43. PubMed ID: 7521089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.
    Ryall RL
    World J Urol; 1997; 15(3):155-64. PubMed ID: 9228722
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary enzymes and calcium oxalate urolithiasis.
    Khan SR; Shevock PN; Hackett RL
    J Urol; 1989 Sep; 142(3):846-9. PubMed ID: 2570167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of dietary excesses in animal protein and in sodium on the composition and the crystallization kinetics of calcium oxalate monohydrate in urines of healthy men.
    Kok DJ; Iestra JA; Doorenbos CJ; Papapoulos SE
    J Clin Endocrinol Metab; 1990 Oct; 71(4):861-7. PubMed ID: 2401715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of various calcium intakes on calcium-oxalate crystalluria in rats on sodium-oxalate diet.
    da Silva SL; Hennequin C; Droz D; Bader C; Daudon M; Drüeke T; Lacour B
    Nephrol Dial Transplant; 1994; 9(8):1090-6. PubMed ID: 7800206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alkalinizing treatment as a preventative of recurrent calcium oxalate lithiasis].
    Cifuentes Delatte L
    Arch Esp Urol; 1991 Oct; 44(8):903-10. PubMed ID: 1796852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Estimation of 24-h excretion of some promotors and inhibitors of crystallization and degree of urine saturation with calcium oxalate in calcium urinary calculi].
    Boruczkowska A
    Pol Arch Med Wewn; 1994 Oct; 92(4):289-98. PubMed ID: 7854956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosaminoglycans, uric acid and calcium oxalate urolithiasis.
    Grases F; Costa-Bauzá A; March JG; Masárová L
    Urol Res; 1991; 19(6):375-80. PubMed ID: 1759332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium is neither a risk nor a protective factor in urolithiasis?
    Singh PP; Pendse AK; Hada P; Nagori PC; Rathore V; Dashora PK
    Urol Res; 1987; 15(2):105-8. PubMed ID: 3590427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of two new polysaccharides on growth, agglomeration and zeta potential of calcium phosphate crystals.
    Boevé ER; Cao LC; Deng G; De Bruijn WC; Schröder FH
    J Urol; 1996 Jan; 155(1):368-73. PubMed ID: 7490888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the effect of triterpenes on urinary risk factors of stone formation in pyridoxine deficient hyperoxaluric rats.
    Vidya L; Lenin M; Varalakshmi P
    Phytother Res; 2002 Sep; 16(6):514-8. PubMed ID: 12237806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sodium pentosan polysulfate and citrate on urinary stone formation in hyperoxaluric rats.
    Ishii K; Sugimoto T; Kanazawa T; Yoneda Y; Kamikawa S; Limori H; Nakatani T; Yamamoto K; Kishimoto T
    Int J Urol; 1996 Jan; 3(1 Suppl):S67-8. PubMed ID: 24304029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.